AUL says Ohio Federal District Court win in abortion-inducing drug case could have "national impact"

WASHINGTON, D.C. (05-25-11) – A first-in-the-nation law that restricts the abortion industry’s use of abortion-inducing RU-486 survived another round this week in a case that began 7 years ago. A federal district court in Ohio ruled that the law was “not vague” but could be readily understood by the abortion providers industry. Americans United for Life President and CEO Dr. Charmaine Yoest noted that AUL has twice argued that position in two separate amicus briefs during the protracted legal battle and predicted the case would have “national impact.”

“The abortion industry has cavalierly given abortion-inducing drugs to women against FDA protocols,” said Dr. Yoest. “The courts affirmed the right of states to protect women by requiring proper use of these dangerous drugs. And AUL model legislation on the regulation of RU-486 has been made available nationwide with that protection.”

The Ohio regulation in dispute requires abortion providers to comply with the FDA- approved protocol for the drug. On its own website, Planned Parenthood freely admits that RU-486 is given to women who are further along in their pregnancies than the FDA recommends. Ohio enacted the regulation in 2004 after women across the nation died or were severely injured following such “off-label” use of RU-486.

To read AUL’s amicus briefs in support of the Ohio law, one before the Sixth Circuit Court of Appeals, and one before the Ohio Supreme Court, click here. In both instances, AUL represented members of the U.S. Congress who supported the regulation, including current Speaker of the House John Boehner. 

For more information on RU-486 and AUL’s model act regulating abortion-inducing drugs, go here.